子宫内膜异位症相关输尿管子宫内膜异位症与肾积水的腹腔镜处理
该回顾性队列研究纳入2004年11月至2013年12月期间因深部浸润型子宫内膜异位症手术的658例患者,其中198例有输尿管子宫内膜异位症需输尿管松解术,28例合并输尿管扩张和肾积水。28例中15例行输尿管松解术、12例行再吻合术、1例行再植入术;术后疼痛改善,3例出现并发症,1例需再次手术。逻辑回归分析显示阴道切口、膀胱切口、切口数量和既往手术次数为198例患者并发症的独立危险因素。结论认为腹腔镜输尿管松解、再吻合和再植入术可行、安全、有效,并发症似乎与切口数量相关。
要点
- 深部浸润型子宫内膜异位症患者中应怀疑输尿管子宫内膜异位症。
- 腹腔镜输尿管松解、再吻合和再植入术是可行、安全、有效的治疗方法。
- 完全腹腔镜切除可行且并发症少,并发症似乎与切口数量相关。
核心结论
- 腹腔镜辅助输尿管松解术、输尿管再吻合术和输尿管再植入术是输尿管子宫内膜异位症的可行、安全、有效的治疗方法。
- 完全腹腔镜切除可行且并发症少,并发症似乎与切口数量相关。
- 所有深部浸润型子宫内膜异位症病例均应怀疑输尿管子宫内膜异位症。
研究设计与样本
- 经机构审查委员会批准的回顾性队列研究,连续纳入因累及输尿管伴肾积水的深部浸润型子宫内膜异位症接受手术的患者(加拿大任务组分类III)。
- 研究于一所大学医院进行,2004年11月至2013年12月期间共658例患者因深部浸润型子宫内膜异位症接受手术。
- 658例中198例有输尿管子宫内膜异位症需输尿管松解术,198例中28例被确定为子宫内膜异位症相关的输尿管扩张和肾积水。
主要发现
- 28例中15例行输尿管松解术、12例行输尿管再吻合术、1例行输尿管再植入术。
- 所有28例均因盆腔或腹部其他部位子宫内膜异位症同时接受手术;12例(42.9%)接受肠道手术,5例(17.9%)接受膀胱手术。
- 术后疼痛改善:痛经数字疼痛评分量表(0-10分)术前为7.25,短期随访为1.73,长期随访为0.25。
- 28例输尿管肾积水患者中记录到3例并发症,其中1例需手术再干预。
- 198例患者中,逻辑回归分析发现阴道切口(比值比=2.08;95%CI 0.92-4.73)、膀胱切口(比值比=8.77;95%CI 3.25-23.63)、切口数量(比值比=2.12;95%CI 1.29-3.47)和既往手术次数(比值比=1.26;95%CI 0.93-1.71)为并发症的独立危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: STUDY OBJECTIVE: To evaluate if laparoscopic treatment of ureteral endometriosis is feasible, safe, and effective and to determine if ureteral dilatation and/or the number of incisions increases complications. DESIGN: An institutional review board-approved retrospective cohort study of consecutive patients who underwent surgery for deep infiltrating endometriosis involving the ureter with hydronephrosis (Canadian Task Force classification III). SETTING: A university hospital. PATIENTS: Of 658 patients who had surgery for deep infiltrating endometriosis between November 2004 and December 2013, 198 of the 658 patients had ureteral endometriosis and required ureterolysis, and 28 of the 198 patients were identified with ureteral dilatation and hydronephrosis associated with endometriosis. INTERVENTIONS: Of these 28 cases, 15 ureterolyses, 12 reanastomoses, and 1 reimplantation were performed. MEASUREMENTS AND MAIN RESULTS: Medical, operative, and pathological data on the evolution of pain, urinary complaints, fertility, complications, and recurrences were collected from clinical records. Additionally, telephone interviews were performed for the follow-up of long-term outcomes. All 28 patients had concomitant surgical procedures because of endometriosis elsewhere in the pelvis or abdomen; 12 (42.9%) underwent surgery of the bowel, whereas 5 (17.9%) had bladder surgery. The evolution of pain after surgery showed a positive response (mean dysmenorrhea evaluation measured by the Numeric Pain Rating Scale from 0-10 preoperatively at the short-term follow-up and the long-term follow-up: 7.25-1.73 and 0.25, respectively). Three complications were noted in the group of 28 patients with ureterohydronephrosis; 1 required surgical reintervention. Logistic regression analyses found vaginal incision (odds ratio = 2.08; 95% CI 0.92-4.73), bladder incision (odds ratio = 8.77; 95% CI 3.25-23.63), number of incisions (odds ratio = 2.12; 95% CI 1.29-3.47), and number of previous surgeries (odds ratio = 1.26; 95% CI 0.93-1.71) as independent risk factors for complications in the group of 198 patients. Three patients underwent reoperation in the group of 28 patients: 1 for ureterovaginal fistula, 1 for persistent ureter dilatation and hydronephrosis, and 1 for persistent pain. CONCLUSION: Laparoscopically assisted ureterolyses, ureteral reanastomoses, and ureteral reimplantation are feasible, safe, and effective treatments for ureteral endometriosis. Complete laparoscopic excision is possible with minimal complications, which seem to be associated with the number of incisions. Ureteral endometriosis should be suspected in all cases of deep infiltrating endometriosis.
引用
- Alves J, Puga M, Fernandes R, et al. Laparoscopic Management of Ureteral Endometriosis and Hydronephrosis Associated With Endometriosis. J Minim Invasive Gynecol. 2017. PMID: 28089810. doi:10.1016/j.jmig.2016.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。